Saroglitazar for the treatment of NASH: the PPAR story goes on!
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32024
Abstract: Despite intensive research, no drug has to date been approved for the management of NAFLD, and many clinical trials have failed, including some recent large phase 3 trials. This has in part to do with… read more here.
Keywords: saroglitazar treatment; treatment nash; story goes; nash ppar ... See more keywords
Letter to the Editor: Saroglitazar for treatment of NAFLD and NASH.
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32094
Abstract: Despite being one of the common diseases, the treatment options for nonalcoholic steatohepatitis (NASH) are still limited. Recently, Gawrieh et al. demonstrated significant improvement in liver enzymes and liver fat content (LFC) in nonalcoholic fatty… read more here.
Keywords: saroglitazar treatment; treatment; editor saroglitazar; nafld nash ... See more keywords